IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ridgeback Capital Investments L.P.

Q4 2013 Holdings

Filed 2014-05-15 | 5 holdings | $79.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Sangamo Biosciences Inc(SGMO)Common Stock800677106$40.3K2,900,00050.9%
Celldex Therapeutics IncCommon Stock15117B103$24.8K1,025,00031.4%
Stemline Therapeutics IncCommon Stock85858C107$9.9K506,69912.6%
Arrowhead Research CorporationCommon Stock042797209$3.0K279,3613.8%
Geron Corporation(GERN)Common Stock374163103$1.1K225,0001.3%